dc.contributor.author | Lewis, RS | |
dc.contributor.author | George, A | |
dc.contributor.author | Rusby, JE | |
dc.date.accessioned | 2020-12-01T13:27:11Z | |
dc.date.issued | 2018-06 | |
dc.identifier.citation | Gland surgery, 2018, 7 (3), pp. 325 - 336 | |
dc.identifier.issn | 2227-684X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4248 | |
dc.identifier.eissn | 2227-8575 | |
dc.identifier.doi | 10.21037/gs.2018.04.01 | |
dc.description.abstract | Nipple-sparing mastectomy is a valuable addition to the options available for women at high risk of developing breast cancer. In this review, we summarize current knowledge about the high-risk genes, BRCA1 , BRCA2 and TP53 and the associated guidelines with regard to risk-reducing surgery. We consider other genetic risks and high-risk lesions. We discuss the literature on bilateral mastectomy for breast cancer risk-reduction, and the results of nipple-sparing mastectomy in particular. Finally, we report on patient satisfaction with these procedures and the impact that nipple-sparing mastectomy may have on women at high-risk of breast cancer. | |
dc.format | Print | |
dc.format.extent | 325 - 336 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
dc.title | Nipple-sparing mastectomy in women at high risk of developing breast cancer. | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.21037/gs.2018.04.01 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
rioxxterms.licenseref.startdate | 2018-06 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Gland surgery | |
pubs.issue | 3 | |
pubs.notes | No embargo | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR | |
pubs.publication-status | Published | |
pubs.volume | 7 | |
pubs.embargo.terms | No embargo | |
dc.contributor.icrauthor | Rusby, Jennifer | |